MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 70 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $347,000 | +79.8% | 49,960 | 0.0% | 0.01% | +62.5% |
| Q4 2018 | $193,000 | -52.0% | 49,960 | -33.7% | 0.01% | -42.9% |
| Q3 2018 | $402,000 | +8.6% | 75,367 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $370,000 | -39.0% | 75,367 | 0.0% | 0.01% | -39.1% |
| Q1 2018 | $607,000 | -21.6% | 75,367 | -0.1% | 0.02% | -14.8% |
| Q4 2017 | $774,000 | -38.5% | 75,467 | -12.8% | 0.03% | -38.6% |
| Q3 2017 | $1,259,000 | – | 86,565 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Standard LLC | 869,354 | $2,895,000 | 3.47% |
| 22NW, LP | 1,241,896 | $4,136,000 | 2.24% |
| Newtyn Management, LLC | 1,199,606 | $3,995,000 | 1.46% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 186,198 | $620,000 | 0.35% |
| Yakira Capital Management, Inc. | 66,934 | $223,000 | 0.10% |
| Sepio Capital, LP | 210,534 | $701,000 | 0.08% |
| Nantahala Capital Management | 747,635 | $2,490,000 | 0.08% |
| Watson Rebecca | 3,068 | $10,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 61,700 | $205,000 | 0.00% |
| WEBSTER BANK, N. A. | 3,055 | $10,000 | 0.00% |